Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats

Arima,Shiho; Uto,Hirofumi; Ibusuki,Rie; Kumamoto,Ryo; Tanoue,Shirou; Mawatari,Seiichi; Oda,Kohei; Numata,Masatsugu; Fujita,Hiroshi; Oketani,Makoto; Ido,Akio; Tsubouchi,Hirohito

doi:10.3892/ijmm.2013.1544

Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats

Authors:
- Shiho Arima
- Hirofumi Uto
- Rie Ibusuki
- Ryo Kumamoto
- Shirou Tanoue
- Seiichi Mawatari
- Kohei Oda
- Masatsugu Numata
- Hiroshi Fujita
- Makoto Oketani
- Akio Ido
- Hirohito Tsubouchi
View Affiliations

Affiliations: Digestive and Lifestyle Diseases, Department of Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan, Department of HGF Tissue Repair and Regenerative Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan
Published online on: November 1, 2013 https://doi.org/10.3892/ijmm.2013.1544
Pages: 68-76

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The effect of hypertension on non-alcoholic fatty liver disease (NAFLD) remains unclear at the molecular level. In this study, we investigated the effects of hypertension on the degree of hepatic steatosis, liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined (CDAA) diet in spontaneously hypertensive rats (SHRs). Seven-week-old male SHRs were fed standard chow with high or normal salt concentrations for 7 weeks, followed by a CDAA diet containing high or normal salt for an additional 8 or 24 weeks. Hepatic steatosis was assessed using hepatic triglyceride levels and Oil red O staining. Hepatic fibrosis was evaluated using Sirius red and Azan staining. Systolic blood pressure (SBP) gradually increased with a high-salt diet and was significantly higher after 7 weeks of feeding with high-salt vs. normal-salt chow. After 8 weeks on the CDAA diet, the degree of hepatic steatosis did not differ between the high-salt and normal-salt groups; however, alanine aminotransferase and fasting blood glucose levels were significantly higher and hepatic mRNA levels for interleukin (IL)-10 and heme oxygenase (HO)-1 were significantly lower in the high-salt group compared with the normal-salt group. After 24 weeks on the CDAA diet, the high-salt group had significantly more severe hepatic fibrosis and a higher hepatic mRNA expression of α-smooth muscle actin and lower hepatic IL-10 and HO-1 mRNA levels compared with the normal-salt group. In conclusion, our results indicate that hypertension is a potential risk factor for liver injury and hepatic fibrosis through glucose intolerance and decreased IL-10-mediated or HO-1-induced anti-inflammatory mechanisms.

View Figures

View References

1	Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF and Zein NN: The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 51:1972–1978. 2010. View Article : Google Scholar : PubMed/NCBI
2	Yasui K, Hashimoto E, Tokushige K, et al: Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma. Hepatol Res. 42:767–773. 2012. View Article : Google Scholar : PubMed/NCBI
3	Adams LA, Lymp JF, St Sauver J, et al: The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 129:113–121. 2005. View Article : Google Scholar : PubMed/NCBI
4	Hamaguchi M, Kojima T, Takeda N, et al: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 143:722–728. 2005. View Article : Google Scholar : PubMed/NCBI
5	López-Suárez A, Guerrero JM, Elvira-González J, Beltrán-Robles M, Cañas-Hormigo F and Bascuñana-Quirell A: Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastroenterol Hepatol. 23:1011–1017. 2011.
6	Dixon JB, Bhathal PS and O’Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 121:91–100. 2001. View Article : Google Scholar : PubMed/NCBI
7	Nakae D, Yoshiji H, Mizumoto Y, et al: High incidence of hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats. Cancer Res. 52:5042–5045. 1992.PubMed/NCBI
8	Matsui H, Ando K, Kawarazaki H, et al: Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension. 52:287–294. 2008. View Article : Google Scholar : PubMed/NCBI
9	Hsu CT: Ultrastructural changes in liver damage induced by carbon tetrachloride in spontaneously hypertensive rats and Wistar-Kyoto rats. J Auton Nerv Syst. 70:79–83. 1998. View Article : Google Scholar : PubMed/NCBI
10	Ikuta T, Kanno K, Arihiro K, et al: Spontaneously hypertensive rats develop pronounced hepatic steatosis induced by choline-deficient diet: Evidence for hypertension as a potential enhancer in non-alcoholic steatohepatitis. Hepatol Res. 42:310–320. 2012. View Article : Google Scholar
11	Svoboda DS and Kawaja MD: Changes in hepatic protein expression in spontaneously hypertensive rats suggest early stages of non-alcoholic fatty liver disease. J Proteomics. 75:1752–1763. 2012. View Article : Google Scholar
12	Amarapurkar DN, Hashimoto E, Laurentius LA, et al: Howcommon is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol. 22:788–793. 2007. View Article : Google Scholar : PubMed/NCBI
13	Lewis JR and Mohanty SR: Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci. 55:560–578. 2010. View Article : Google Scholar : PubMed/NCBI
14	Kojima S, Watanabe N, Numata M, Ogawa T and Matsuzaki S: Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 38:954–961. 2003.PubMed/NCBI
15	Radu C, Grigorescu M, Crisan D, Lupsor M, Constantin D and Dina L: Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients. J Gastrointestin Liver Dis. 17:255–260. 2008.PubMed/NCBI
16	Jimba S, Nakagami T, Takahashi M, et al: Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 22:1141–1145. 2005. View Article : Google Scholar : PubMed/NCBI
17	Matrougui K, Abd Elmageed Z, Kassan M, et al: Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol. 178:434–441. 2011. View Article : Google Scholar : PubMed/NCBI
18	Kassan M, Galan M, Partyka M, Trebak M and Matrougui K: Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol. 31:2534–2542. 2011.
19	Cintra DE, Pauli JR, Araújo EP, et al: Interleukin-10 is a protective factor against diet-induced insulin resistance in liver. J Hepatol. 48:628–637. 2008. View Article : Google Scholar : PubMed/NCBI
20	Shen XD, Ke B, Zhai Y, et al: Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant. 5:1793–1800. 2005. View Article : Google Scholar : PubMed/NCBI
21	Yu HP, Choudhry MA, Shimizu T, et al: Mechanism of the salutary effects of flutamide on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of estrogen receptor-β-dependent HO-1. J Leukoc Biol. 79:277–284. 2006.PubMed/NCBI
22	Liu FC, Hwang TL, Lau YT and Yu HP: Mechanism of salutary effects of astringinin on rodent hepatic injury following trauma-hemorrhage: Akt-dependent hemeoxygenase-1 signaling pathways. PLoS One. 6:e259072011. View Article : Google Scholar : PubMed/NCBI
23	Devey L, Mohr E, Bellamy C, et al: c-Jun terminal kinase-2 gene deleted mice overexpress hemeoxygenase-1 and are protected from hepatic ischemia reperfusion injury. Transplantation. 88:308–316. 2009. View Article : Google Scholar : PubMed/NCBI
24	Yu HP, Yang SC, Lau YT and Hwang TL: Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage. Surgery. 148:103–109. 2010. View Article : Google Scholar : PubMed/NCBI
25	Elmarakby AA, Faulkner J, Baban B and Sullivan JC: Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats. Int J Hypertens. 2012:9572352012. View Article : Google Scholar : PubMed/NCBI
26	Hou HS, Liao CL, Sytwu HK, et al: Deficiency of interleukin-15 enhances susceptibility to acetaminophen-induced liver injury in mice. PLoS One. 7:e448802012. View Article : Google Scholar : PubMed/NCBI
27	Zhou YC, Chen S, Cao JJ, Chen SY, Xie YF and Niu QX: Adenovirus-mediated viral interleukin-10 gene transfer prevents concanavalin A-induced liver injury. Dig Liver Dis. 44:398–405. 2012. View Article : Google Scholar : PubMed/NCBI
28	Zhang LJ, Zheng WD, Shi MN and Wang XZ: Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver. World J Gastroenterol. 12:1918–1923. 2006.PubMed/NCBI
29	Lee TS and Chau LY: Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 8:240–246. 2002. View Article : Google Scholar : PubMed/NCBI
30	Gunnett CA, Heistad DD and Faraci FM: Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide. Diabetes. 51:1931–1937. 2002. View Article : Google Scholar : PubMed/NCBI
31	Zhang LJ, Zheng WD, Chen YX, et al: Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Hepatogastroenterology. 54:2092–2098. 2007.PubMed/NCBI
32	Hamaguchi M, Kojima T, Takeda N, et al: Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 13:1579–1584. 2007. View Article : Google Scholar : PubMed/NCBI
33	Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G and Bellentani S: Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 42:44–52. 2005. View Article : Google Scholar : PubMed/NCBI
34	Donati G, Stagni B, Piscaglia F, et al: Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut. 53:1020–1023. 2004. View Article : Google Scholar : PubMed/NCBI
35	Pollare T, Lithell H and Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 39:167–174. 1990. View Article : Google Scholar : PubMed/NCBI
36	Raitakari OT, Porkka KV, Rönnemaa T, et al: The role of insulin in clustering of serum lipids and blood pressure in children and adolescents. The cardiovascular risk in young finns study. Diabetologia. 38:1042–1050. 1995. View Article : Google Scholar : PubMed/NCBI
37	Allemann Y, Horber FF, Colombo M, et al: Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet. 341:327–331. 1993. View Article : Google Scholar : PubMed/NCBI
38	Ogihara T, Asano T, Ando K, et al: High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension. 40:83–89. 2002. View Article : Google Scholar : PubMed/NCBI
39	Ogihara T, Asano T and Fujita T: Contribution of salt intake to insulin resistance associated with hypertension. Life Sci. 73:509–523. 2003. View Article : Google Scholar : PubMed/NCBI
40	Petta S, Macaluso FS, Barcellona MR, et al: Serum γ-glutamyl transferase levels, insulin resistance and liver fibrosis in patients with chronic liver diseases. PLoS One. 7:e511652012.
41	Aithal GP, Thomas JA, Kaye PV, et al: Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology. 135:1176–1184. 2008. View Article : Google Scholar
42	Cohen JC, Horton JD and Hobbs HH: Human fatty liver disease: old questions and new insights. Science. 332:1519–1523. 2011. View Article : Google Scholar : PubMed/NCBI
43	Day CP and James OF: Steatohepatitis: a tale of two ‘hits’? Gastroenterology. 114:842–845. 1998.